![]() | Only 14 pages are availabe for public view |
Abstract Postoperative pain is the most undesired consequence of surgery, and if not managed adequately, can lead to delayed recovery and increased hospital stay.Though opiates were used for long time to attenuate such immediate postoperative pain, yet still this was at the expense of concurrently inducing sedation, nausea and vomiting, adding more to the possibility of in-hospital stay. Thus, optimizing postoperative pain relief, not only to sub-serve reduction of its intensity but to also enhance the recovery and shorten length of stay became the broader target of multimodal pain control regimens nowadays. That is why searching for a drug that would be effective in reducing pain, safe from major adverse effects and can mean while possess an opioid-sparing potentiality would be a merit so as to improve the success rate of upper limb surgeries. |